bf/NASDAQ:NTRA_icon.png

NASDAQ:NTRA

Natera

  • Stock

USD

Last Close

198.48

06/11 22:17

Market Cap

13.70B

Beta: 1.22

Volume Today

822.75K

Avg: 1.35M

PE Ratio

−15.26

PFCF: −21.14

    Description

    Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier...Show More

    Earnings

    Earnings per Share (Estimate*)

    -1.5-1-0.52018-08-082020-08-052022-08-042024-02-282024-11-13

    Revenue (Estimate*)

    100M200M300M400M2018-08-082020-08-052022-08-042024-02-282024-11-13

    *Estimate based on analyst consensus